Smart Infusion Pumps Market size is estimated to reach $13.1 billion by 2030; Rising demand for precision in medication delivery, increasing incidence of chronic diseases and demand for continuous infusion therapy due to geriatric population drive th

Smart Infusion Pumps Market size is estimated to reach $13.1 billion by 2030, growing at a CAGR of 7.1% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “Smart Infusion Pumps Market – By Product Type (Large Volumetric Infusion Systems, Patient Controlled Analgesia Pumps, Syringe Infusion Systems, Electronic- Ambulatory Infusion Systems, Implantable Infusion Systems, MRI-compatible IV Infusion Pump Systems, Disposable Elastomeric Infusion Systems and Others), By Application (Chemotherapy/Oncology, Pediatrics/Neonatology, Gastroenterology, Hematology, Diabetes and Others) By End User (Hospitals, Ambulatory Surgical Centers, Home Care, Specialty Clinics, Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030.”

The rising prevalence of chronic diseases along with the growing geriatric population is driving the demand for smart infusion pumps. Additionally, the demand for precision in medication delivery is further driving the market demand 

Geographically, North America held the largest share with 39% of the overall market in 2023 and it is poised to dominate the market over the period 2024-2030. North America has a high number of populations with conditions like diabetes and cancer. According to a report by the Organization for Economic Cooperation and Development (OECD) released in November 2023, Mexicans have the highest rate of diabetes, that affects 16.9% of the population. According to the Association of Cancer Society, in 2023, a little over 1.9 million new cases of cancer are expected to be diagnosed in the United States. As such, there is a high demand for smart infusion pumps in the region. 

The rising prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders is driving demand for continuous and precise infusion therapies. According to the IDF Annual Report 2022 prepared by the International Diabetes Federation (IDF), the number of people living with diabetes has more than tripled since 2000, from 151 million to 537 million people in 2021. With over 141 million people with diabetes, China accounts for one in four people with the condition worldwide. Smart infusion pumps are becoming essential tools in managing these long-term health conditions by enabling controlled medication delivery with minimal patient supervision. With chronic diseases requiring frequent and ongoing medication, infusion pumps support effective, reliable drug administration. As lifestyle-related illnesses rise globally, healthcare providers are turning to advanced infusion technologies to improve patient outcomes and reduce hospitalizations particularly in home care and outpatient settings where patients can benefit from convenient, uninterrupted infusion solutions.

With an aging global population, continuous infusion therapy has become essential in geriatric care. Elderly patients often require ongoing infusion treatments for managing age-related health conditions like heart disease, arthritis, Parkinsons and weakened immune systems. Smart infusion pumps enable precise, consistent drug delivery providing an ideal solution for this demographic. According to the latest projections by the U.S. Census Bureau, the population of individuals aged 65 and older is projected to reach 74 million by 2030. Moreover, home care adoption is rising among the elderly who prefer convenient, at-home medical solutions. Continuous infusion therapy ensures that seniors receive uninterrupted treatment while minimizing hospital visits enhancing their quality of life and supporting better long-term health management in the comfort of their homes.

players in the Smart Infusion Pumps Market are BD, Medtronic Plc, Smiths Medical, MOOG Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, CareFusion Corporation, ICU Medical, Inc., Baxter International Inc among others.

The Diabetes Injection Pens Market -  The Diabetes Injection Pens Market Size is estimated to reach $11.2 billion by 2028 and it is poised to grow at a CAGR of 6.1% over the forecast period of 2023-2028. The market is primarily driven due to the growing cases of diabetes.

Human Insulin Market - Human Insulin Market size is forecast to reach $27.81 billion by 2025, growing at a CAGR of 5.40% during the forecast period 2020-2025. The rising number of diabetic patients and technological advancements in insulin delivery devices are the major factors driving the growth of the market.

Alzheimer’s Drugs Market -  Alzheimer’s Drugs Market size in 2019 is estimated to be $3.5 billion, growing at a CAGR of 6.8% during the forecast period 2020-2025.